Project

Alzheimer’s disease (AD) is a vital medical/social problem in EU, but currently, there is not an effective method for the early diagnosis of AD.

Integrated by neuroscientists, nanotechnologists, molecular imaging experts, clinicians and Small/Medium/Large Enterprises in an exclusive consortium, PANA project seeks the goal to develop new effective early diagnostic and therapeutic strategies to help in delaying the appearance of the most adverse symptoms of this disease, using nanotechnology.

News & events

Consortium

This project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 686009

Contact

Clinical Neuroscience Research Laboratory
University Clinical Hospital Santiago
A Building, -4 Floor
E15706 A Coruña, Spain
View map